Suggested involvement of ketone bodies in the pathogenesis of the metabolic syndrome

Medical Hypotheses

Volumn 80, Issue 5, 2013, Pages 578-581

  Alexandre, Adolfo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOACETIC ACID; ALPHA TOCOPHEROL; BUTYRIC ACID; GLUTAMIC ACID; HYDROGEN PEROXIDE; KETONE BODY; LIPOPOLYSACCHARIDE; PYRUVIC ACID; SHORT CHAIN FATTY ACID;

ARTICLE; BRAIN MITOCHONDRION; CELL MEMBRANE PERMEABILITY; CITRIC ACID CYCLE; COLON MUCOSA; ENZYME ACTIVITY; FAT INTAKE; INSULIN RESISTANCE; KETOGENESIS; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; COLON; HUMANS; HYDROGEN PEROXIDE; KETONE BODIES; METABOLIC SYNDROME X; MITOCHONDRIA; MODELS, BIOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 84875601518     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.01.029     Document Type: Article

References (44)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Vincent H.K., Taylor A.G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006, 30:400-418.
3. Rossi R., Dorig S., Del prete E., Sharrer E. Suppression of feed intake after parenteral administration of d-(-)-hydroxybutirate in pygmy goats. J Vet Med 2000, 47:9-16.
4. Langhans W., Pantel K., Scharrer E. Ketone kinetics and d-(-)-3-hydroxybutyrate-induced inhibition of feeding in rats. Physiol Behav 1985, 34:579-582.
5. Carpenter R.G., Grossman S.P. Plasma fat metabolites and hunger. Physiol Behav 1983, 30:57-63.
6. Yi W., Fu P., Fan Z., Aso H., Tian C., Meng Y., et al. Mitochondrial HMGCoA synthase partially contributes to antioxidant protection in the kidney of stroke-prone spontaneously hypertensive rats. Nutrition 2010, 26:1176-1180.
7. 2 production. J Bioenerg Biomembr 2011, 43:359-366.
8. Veech R. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004, 70:309-319.
9. Roediger W.E. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982, 83:424-429.
10. Peng L., Li Z.-R., Green R.S., Holzman I.R., Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in caco-2 cell monolayers. J Nutr 2009, 139:1619-1625.
11. Cherbuy C., Andrieux C., Honvo-Houeto E., et al. Expression of mitochondrial HMGCoA synthase and glutaminase in the colonic mucosa is modulated by bacterial species. Eur J Biochem 2004, 271:87-95.
12. Vanhoutvin S.A.L.W., Troost F.J., Hamer H.M., et al. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One 2009, 4:e6759.
13. Hamer H.M., Jonkers D.M.A.E., Bast A., et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2008, 28:88-93.
14. Fitch M.D., Fleming S.E. Metabolism of short-chain fatty acids by rat colonic mucosa in vivo. Am J Physiol Gastrointest Liver Physiol 1999, 277:G31-G40.
15. Luciano L., Hass R., Busch W., von Engelhardt W., Reale E. Withdrawal of butyrate from the colonic mucosa triggers " mass apoptosis" primarily in the G0/G1 phase of the cell cycle. Cell Tissue Res 1996, 286:81-92.
16. Delzenne N., Cani P.D. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 2011, 31:15-31.
17. Cani P.D., Neyrinck A.M., Fava F., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia 2007, 50:2374-2383.
18. Hotamisligil G., Peraldi P., Budavari A., Ellis R., White M., Spigelman B. IRS 1- mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996, 271:665-668.
19. Cani P.D., Amar J., Iglesias M.A., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
20. Cani P.D., Bibiloni R., Knauf C., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
21. Brun P., Castagliuolo I., Di Leo V., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of non-alcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007, 292:g518-g525.
22. Delzenne N.M., Cani P.D., Neyrinck A.M. Modulation of glucagons-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 2007, 137:2547s-2551s.
23. Cani P.D., Possemiers S., Van de Viele T., et al. Changes ion gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability. Gut 2009, 58:1091-1103.
24. Nappo F., Esposito K., Cioffi M., et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients. Role of fat and carbohydrate meals. J Am Coll Card 2002, 39:1145-1150.
25. Goshal S., Witta J., Zhong J., de Villiers W., Eckardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009, 50:90-97.
26. Bjorneboe A., Bjorneboe Gunn-Elin A., Drevon C.A. Absorption, transport and distribution of vitamin E. J Nutr 1990, 120:233-242.
27. Araki Y., Katoh T., Ogawa A., et al. Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med 2005, 39:769-780.
28. Erdelyi H., Levenkova N., Llin E.I., et al. Western style diets induce oxidative stress and dysregulate immune responses in the colon in a mouse model of sporadic colon cancer. J Nutr 2009, 139:2072-2078.
29. Li H., Lelliott C., Hakansson P., et al. Intestinal, adipose and liver inflammation in diet-induced obese mice. Metabolism 2008, 57:1704-1710.
30. Milder J.B, Liang L.-P, Patel M. Acute oxidative stress and systemic Nrf2 activation by ketogenic diet. Neurobiol Dis 2010, 40:238-244.
31. Dashti H.M., Hussein T., Asfar S.K., et al. Long term effects of a ketogenic diet in obese patients. Exp Clin Cardiol 2004, 9:200-204.
32. Duncan S.H., Belenguer A., Holtrop G., et al. Reduced dietary intake of carbohydrates by obese subjects by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ microbial 2007, 1073-1078.
33. Pendayala F., Neff L.M., Suares-Farinas M., Holt P.R. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr 2011, 93:234-242.
34. Bajka B.H., Clarke J.M., Cobiac L., Topping D.L. Butyrylated starch protects colonocyte DNA against dietary protein-induced damage in rats. Carcinogenesis 2008, 29:2169-2174.
35. Russo I., Luciani A., De Cicco P., Troncone E., Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. Plos One 2012, 7:e32841.
36. McOrist A.L., Miller R.B., Bird A.R., Keogh J.B., Noakes M., Topping D.L., et al. Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr 2011, 141:883-889.
37. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., et al. Mictrobiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18:190-195.
38. Babidge W., Millard S., Roediger W. Sulfides impair short chain fatty acid beta-oxidation at acylCoA dehydrogenase level in colonocytes. Implications for ulcerative colitis. Mol Cell Biochem 1998, 181:117-124.
39. Zhang C., Zhang M., Wang S., et al. Interactions between gut microbiota host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2009, 1-10.
40. Cremin J.D., Fitch M.D., Fleming S.E. Glucose alleviates ammonia-induced inhibition of short-chain fatty acid metabolism in rat colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2003, 285:G105-G114.
41. Sangupta S., Peterson T.R., Laplante M., OH S., Sabatini D. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010, 468:1100-1104.
42. Chang G.R., Chiu Y.-S., Wu Y.Y., et al. Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice. J Pharmacol Sci 2009, 109:496-503.
43. Kimura N., Tokunga C., Dalal S., et al. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cell 2003, 8:65-79.
44. Pendyala S., Walker J.M., Holt P.R. A high fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 2012, 142:1100-1101.